Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Javier Rampolla is CHIEF FINANCIAL OFFICER at Sensus Healthcare. OQRO lists 2 transactions filed with the SEC under this name, the latest on Apr 22, 2026, each linked to the official Form 4.
CHIEF FINANCIAL OFFICER
Disclosures on record
2
Companies involved
1
1 buy, median −19.6 pts vs S&P 500, beat it 0 of 1 time.
Average −19.6 pts vs S&P 500. Each buy is one disclosure of open-market purchases in one company on one filing date, filed Feb 10, 2025 to Feb 10, 2025, measured from the first close after the filing. Past results, not a forecast.
1 purchase disclosed; 0% of the 1 measured at 90 days finished ahead of the index.
Not ranked: fewer than 10 purchases measured at 90 days. The middle of the 82 ranked insiders is −5.5 pts (median, against the S&P 500).
Equal weight counts every purchase once; by size counts it for its disclosed dollars. Both are measured from the first close after it was reported. Past results describe the past, not a forecast. How this is measured · Leaderboard
Sensus HealthcareSRTS
2 disclosures · Feb 2025 – Apr 2026 · 1 bought
Jul 21, 20223,935disclosed Apr 22
DetailsOfficial recordFeb 10, 2025Bought~$3K
DetailsOfficial recordAs of the latest filing on , Javier Rampolla reported holding 40,745 shares of Sensus Healthcare (SRTS), worth about $95K at the last close of $2 (Nov 13, 2026).
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Sensus Healthcare SRTS | 40,745 | 41K direct | $2 | $95K | Feb 10, 2025 |
Is this Javier Rampolla’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
Javier Rampolla bought shares on the open market in 2025. Sales in 1 of the 5 years since 2022.
Javier Rampolla reported 1 open-market purchase and 1 sale since 2022; purchases in 2025.
| Year | Bought | Sold |
|---|---|---|
| 2025 | $3K1×1 trade | — |
| 2022 | — | $85K1×1 trade |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
On the latest SEC Form 4, dated Feb 10, 2025, Javier Rampolla reported holding 40,745 shares of Sensus Healthcare (SRTS). At the last close of $2 on Nov 13, 2026, that is about $95K. This is the stake disclosed in filings, not a net worth.
Javier Rampolla bought shares on the open market in 2025. Sales in 1 of the 5 years since 2022.
In SEC filings since 2022: the latest open-market purchase is from 2025; the latest open-market sale is from 2022.
Sensus Healthcare (SRTS), from 2022 to 2025: 1 purchase and 1 sale.
Javier Rampolla reported 1 open-market purchase and 1 sale here, 2022 to 2025.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.